Laurel Oak Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$925K Sell
2,554
-64
-2% -$21.9K 0.13% 134
2026
Q1
$921K Sell
2,618
-368
-12% -$131K 0.15% 116
2025
Q4
$977K Buy
+2,986
New +$947K 0.16% 109

Other funds holding AMGN

Laurel Oak Wealth Management's AMGN Position: Q2 2026 in Review

Laurel Oak Wealth Management reduced its Amgen (AMGN) stake by 2.4% in Q2 2026, selling an estimated $21.9K and leaving 2,554 shares worth $925K. The position accounts for 0.13% of the portfolio, ranked #134.

Laurel Oak Wealth Management first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $977K in Q4 2025. 2,083 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Laurel Oak Wealth Management held 2,554 shares of Amgen worth $925K as of Q2 2026.
  • Laurel Oak Wealth Management sold 64 Amgen shares in Q2 2026, an estimated $21.9K.
  • Amgen made up 0.13% of Laurel Oak Wealth Management's portfolio in Q2 2026, its #134 holding.
  • Laurel Oak Wealth Management first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • Laurel Oak Wealth Management's Amgen position peaked at $977K in Q4 2025.
  • 2,083 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Laurel Oak Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.